Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Mass Spectrometry

• Publication date

  2010-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jms.1859PMID 21053377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

  2010cited by this paper
• Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.

  2010cited by this paper
• Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

  2009cited by this paper
• Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure.

  2009cited by this paper
• New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.

  2009cited by this paper
• Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry

  2008cited by this paper
• Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone.

  2007cited by this paper
• Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure: 4′-Methyl-α-pyrrolidinohexanophenone and 4′-methyl-α-pyrrolidinobutyrophenone

  2007cited by this paper
• Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.

  2006cited by this paper
• 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

  2006cited by this paper
• Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry.

  2005cited by this paper
• Identification of cytochrome P450 enzymes involved in the metabolism of 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes

  2005cited by this paper
• Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

  2004cited by this paper
• Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry.

  2003cited by this paper
• Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.

  2003cited by this paper
• Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry.

  2003cited by this paper
• Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography–mass spectrometry

  2002cited by this paper
• Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry.

  2002cited by this paper
• The biotransformation of nitrogen containing xenobiotics to lactams.

  2000cited by this paper
• Detection and identification of pyrovalerone and its hydroxylated metabolite in the rat.

  1996cited by this paper
• Effects of pyrovalerone on peripheral noradrenergic mechanisms.

  1978cited by this paper
• [The psychotropic effect of the Pyrovalerone (F-1983), placebo, the milieu therapy and mental condition of the patients in forensic psychiatry].

  1976cited by this paper
• [Role of central catecholamines in the psychostimulant activity of pyrovalerone].

  1976cited by this paper
• A controlled evaluation of pyrovalerone in chronically fatigued volunteers.

  1973cited by this paper
• Experimentell-psychologische Differenzierung der Wirkung von zwei Psychostimulantien am Menschen (F-1983 und Amphetamin)

  1965cited by this paper
• [Experimental psychological differentiation of the effect of 2 psychostimulants (F-1983 and amphetamine) in humans].

  1965cited by this paper
• [COMPARATIVE PHARMACOLOGICAL STUDY OF A NEW CENTRAL STIMULANT, 1-P-TOTYL-1-OXO-2-PYRROLIDINO-N-PENTANE HCL].

  1963cited by this paper
• Gas‐chromatographische Charakterisierung organischer Verbindungen. Teil 1: Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone

  1958cited by this paper

• Toxicological detection of the new psychoactive substances MDPHP and MDPHpP in human urine samples by elucidation of their urinary metabolites using gas chromatography-mass spectrometry.

  2025cites this paper
• Cardiovascular and locomotor effects of binary mixtures of common ‘bath salts’ constituents: Studies with methylone, methylenedioxypyrovalerone and caffeine in rats

  2025cites this paper
• Characterizing the in vitro metabolic features of seven α-pyrrolidinophenone-derived synthetic cathinone-type new psychoactive substances

  2025cites this paper
• The synthetic cathinones MDPHP and MDPV: comparison of the acute effects in mice, in silico ADMET profiles and clinical reports.

  2024cites this paper
• In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

  2024cites this paper
• Danio rerio embryo as in vivo model for the evaluation of the toxicity and metabolism of pyrovalerone cathinones.

  2024cites this paper
• Cardiovascular and Locomotor Effects of Binary Mixtures of Common “Bath Salts” Constituents: Studies with Methylone, MDPV, and Caffeine in Rats

  2024cites this paper
• Metabolic stability and metabolite profiling of emerging synthetic cathinones

  2023cites this paper
• Study the effect of 3,4-Methylenedioxy methamphetamine on cytochrome P450 2E1 activity

  2022cites this paper
• Analytical techniques for the detection of novel psychoactive substances and their metabolites

  2022cites this paper
• Pharmacological profiling of novel psychoactive substances

  2022cites this paper
• Synthetic cathinones

  2022cites this paper
• Brain Concentrations of MDPV and its Metabolites in Male Rats: Relationship to Pharmacodynamic Effects.

  2022cites this paper
• Toxicological Investigation of a Case Series Involving the Synthetic Cathinone α-Pyrrolidinohexiophenone (α-PHP) and Identification of Phase I and II Metabolites in Human Urine.

  2022cites this paper
• Urinary excretion of silibinin diastereoisomers and their conjugated metabolites in rat and human at different dosages.

  2022cites this paper
• 3,4-Methylenedioxypyrovalerone (MDPV) Sensing Based on Electropolymerized Molecularly Imprinted Polymers on Silver Nanoparticles and Carboxylated Multi-Walled Carbon Nanotubes

  2021cites this paper
• Apoptotic mechanism in human brain microvascular endothelial cells triggered by 4'-iodo-α-pyrrolidinononanophenone: contribution of decrease in antioxidant properties.

  2021cites this paper
• In vitro metabolic profile of mexedrone, a mephedrone analog, studied by high‐ and low‐resolution mass spectrometry

  2021cites this paper
• Toxic plants - Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry.

  2021cites this paper
• Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography–Tandem Mass Spectrometry

  2021cites this paper
• An updated review on synthetic cathinones

  2021cites this paper
• Pharmacokinetics of α-Pyrrolidinovalerophenone in Male Rats with and without Vaccination with an α-Pyrrolidinovalerophenone Vaccine.

  2021cites this paper
• Metabolic Profile of Four Selected Cathinones in Microsome Incubations: Identification of Phase I and II Metabolites by Liquid Chromatography High Resolution Mass Spectrometry

  2021cites this paper
• Synthetic drugs of abuse.

  2021cites this paper
• Toxicological findings in fatal intoxications from synthetic cathinones: a narrative review

  2020cites this paper
• In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)

  2020cites this paper
• Metabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS/MS.

  2020cites this paper
• Studies on the phase I metabolites of the new designer drug 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidine-1-yl)butan-1-one (5-PPDI) in human urine.

  2020cites this paper
• A review of synthetic cathinone-related fatalities from 2017 to 2020.

  2020cites this paper
• Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and α-PBP, in human urine.

  2020cites this paper
• Effect of temperature on 3,4-methylenedioxypyrovalerone (MDPV)-induced metabolome disruption in primary mouse hepatic cells.

  2020cites this paper
• Intoxication cases associated with the novel designer drug 3',4'-Methylenedioxy-α-pyrrolidinohexanophenone (MDPHP) and studies on its human metabolism by high-resolution mass spectrometry.

  2020cites this paper
• Intoxication cases associated with the novel designer drug 3 0 ,4 0 -methylenedioxy- α -pyrrolidinohexanophenone and studies on its human metabolism using high-resolution mass spectrometry

  2020influential citation
• Overview of Common Designer Drugs

  2019cites this paper
• Simultaneous Quantification of the New Psychoactive Substances 3-FMC, 3-FPM, 4-CEC, and 4-BMC in Human Blood using GC-MS

  2019cites this paper
• Synthetic cathinones: an evolving class of new psychoactive substances

  2019influential citation
• Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.

  2019cites this paper
• Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems

  2019influential citation
• The emerging field of wastewater-based epidemiology (WBE)

  2019cites this paper
• LC-High-resolution MS Analysis of the Designer Drugs Methylenedioxy-Pyrovalerone (MDPV) and Methylenedioxy-alpha- pyrolidinobutyrophenone (MDPBP) and Their Main Metabolites in Human Urine

  2018cites this paper
• Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity

  2018cites this paper
• A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics

  2018cites this paper
• Biotransformation and bioactivation reactions – 2017 literature highlights**

  2018influential citation
• Determination and long-term stability of twenty-nine cathinones and amphetamine-type stimulants (ATS) in urine using gas chromatography-mass spectrometry.

  2018cites this paper
• Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells

  2018cites this paper
• Newly Emerging Drugs of Abuse and Their Detection Methods: An ACLPS Critical Review.

  2018cites this paper
• Investigating in-sewer transformation products formed from synthetic cathinones and phenethylamines using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

  2018cites this paper
• Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

  2018influential citation
• Development, Applicability, and Comparison of Bioassays for Metabolism of (New) Psychoactive Substances

  2018cites this paper
• MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.

  2018cites this paper
• New psychoactive substances (NPSs) abuse in Romania: analytical strategies for drug screening in biological samples using high resolution mass spectrometry

  2018cites this paper
• Metabolism of Synthetic Cathinones

  2018cites this paper
• Determination of the Plasma Protein Binding of New Psychoactive Substances

  2018cites this paper
• Synthesis, GC–MS, GC–MS/MS, GC–IR and chromatographic studies on cathinone derivatives related to methylenedioxypyrovalerone (MDPV)

  2018influential citation
• New psychoactive substances—Synthetic stimulants

  2018cites this paper
• Analytical Methods Used for Identification and Determination of Synthetic Cathinones and Their Metabolites

  2018cites this paper
• Multi‐organ dysfunction due to bath salts: are we aware of this entity?

  2017cites this paper
• 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one(α-PVP) の3種の類縁化合物のヒトにおける尿中代謝物及び代謝経路

  2017cites this paper
• Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review

  2017cites this paper
• Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS.

  2017cites this paper
• Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.

  2017cites this paper
• A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature

  2017cites this paper
• Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives.

  2017cites this paper
• Liquid chromatography-tandem mass spectrometry determination of synthetic cathinones and phenethylamines in influent wastewater of eight European cities.

  2017cites this paper
• Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

  2017cites this paper
• Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5‐MAPB, and 5‐API as examples

  2017cites this paper
• Uncovering the hepatotoxic and neurotoxic potential of ß-keto amphetamine (cathinone) derivates: in vitro mechanistic studies.

  2017influential citation
• Microbial biotransformation of five pyrrolidinophenone-type psychoactive substances in wastewater and a wastewater isolated Pseudomonas putida strain.

  2017cites this paper
• The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction

  2017cites this paper
• Solid-phase extraction followed by liquid chromatography-high resolution mass spectrometry to determine synthetic cathinones in different types of environmental water samples.

  2017cites this paper
• GC-MS, MS/MS and GC-IR Analysis of a Series of Methylenedioxyphenyl-Aminoketones: Precursors, Ring Regioisomers and Side-Chain Homologs of 3,4-Methylenedioxypyrovalerone.

  2017cites this paper
• α-Pyrrolidinophenones: a new wave of designer cathinones

  2017cites this paper
• Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

  2017cites this paper
• Report - Analysis of designer drugs in human blood using gas chromatography-mass spectrometry.

  2017cites this paper
• 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions

  2016cites this paper
• Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).

  2016cites this paper
• Pharmacological mechanisms underlying the cardiovascular effects of the “bath salt” constituent 3,4‐methylenedioxypyrovalerone (MDPV)

  2016cites this paper
• Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones

  2016cites this paper
• Product ion tandem mass spectrometric differentiation of regioisomeric side-chain groups in cathinone derivatives.

  2016cites this paper
• Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS.

  2016cites this paper
• The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines

  2016cites this paper
• Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.

  2016cites this paper
• Linear pharmacokinetics of 3,4‐methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects

  2016cites this paper
• In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant.

  2016cites this paper
• First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry

  2016cites this paper
• Mephedrone and 3,4‐Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications

  2016cites this paper
• Characterization of in vitro metabolites of methylenedioxypyrovalerone (MDPV): An N-oxide metabolite formation mediated by flavin monooxygenase.

  2016cites this paper
• Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside I in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC-Q-TOF/MS.

  2016cites this paper
• Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases

  2016influential citation
• Evaluation of Two Different Screening ELISA Assays for Synthetic Cathinones(Mephedrone/Methcathinone and MDPV) with LC-MS Method in IntoxicatedPatients

  2016cites this paper
• Antecedentes del estudio metabólico de MDPV y metilona. Propuesta de un modelo de biotransformación a través de hongos del género Cunninghamella

  2016influential citation
• Chiral Separation and Quantitation of KHAT Designer Drug- Synthetic Cathinones- In Urine And Plasma

  2016cites this paper
• Contribution to the study of the mechanisms of action and neuropsychopharmacological effects of MDMA and new β-ketoamphetamines

  2016cites this paper
• 3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on in vivo metabolism in rat and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in Pseudomonas Putida and wastewater using GC and LC coupled to (HR)-MS techniques.

  2016cites this paper
• Differentiation of cyclic tertiary amine cathinone derivatives by product ion electron ionization mass spectrometry.

  2016cites this paper
• GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case.

  2016cites this paper
• Evaluation of Two Different Screening ELISA Assays for Synthetic Cathinones (Mephedrone/Methcathinone and MDPV) with LC-MS Method in Intoxicated Patients

  2016cites this paper
• Quanti fi cation of Synthetic Cathinones in Rat Brain Using HILIC – ESI-MS/MS

  2016cites this paper
• Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).

  2015cites this paper
• Mass Spectral and Chromatographic Studies on Some Halogenatedphenyl-2-Piperazinopropanones.

  2015cites this paper